NIBIB in the News

Share:

EmailFacebookLinkedInXWhatsAppShare
NIBIB in the News · May 20, 2021

For this episode of the Microsamplify Podcast, we spoke with research scientist Kaitlyn Sadtler, PhD, an Earl Stadtman Tenure-Track Investigator and Chief of the Section for Immunoengineering at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH). In early 2020, Dr. Sadtler and a team of researchers conducted one of the very first serology studies of the novel coronavirus known as SARS-CoV-2, in an effort to identify undetected cases of COVID-19 illness in the United States. Source: Neoteryx

NIBIB in the News · May 6, 2021

Pitt County, North Carolina “is one of two communities in the country that are part of a national study on ramping up at-home testing for coronavirus.” The county “is home to rolling farmland, the city of Greenville, East Carolina University and one of the largest health departments in eastern North Carolina.” Health leaders in the county “said that was why the National Institutes of Health chose the area to test what could be the future of coronavirus screening in the United States.” Source: WRAL=TV Raleigh, NC

NIBIB in the News · May 4, 2021

Chattanooga, TN (WDEF) – The Say Yes! COVID Test At-Home Challenge launched Tuesday. The Hamilton County Health Department, CDC, and National Institute of Health all collaborated for this testing challenge. Source: WDEF News 12 Now

NIBIB in the News · April 23, 2021

Update: The Hamilton County Health Department launched a new initiative to tackle the asymptomatic spread of COVID-19.

The "Say Yes! COVID Test" Challenge campaign kicked off on Tuesday.

The department partnered with the Center for Disease Control and the National Institute of Health to provide county residents with free, rapid, at-home COVID-19 test kits. Source: WRCBtv

NIBIB in the News · April 16, 2021

The FDA’s approval last month of “two rapid at-home antigen tests, Abbott’s BinaxNOW and Quidel’s QuickVue, [which] will soon be sold over the counter on drugstore shelves, without the need for a prescription.” The article says these approvals have critical potential impact on the testing front and will help the US catch up to other developed nations in terms of rapid antigen testing. The piece highlights comments in an interview by Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering, who said, “We are in a risky period with variant growth, incomplete vaccination, return to school, increased population mobility and reduced mask wearing. ... The need to do screening, using accessible tests at home, on a large scale and on a regular cadence, is even more important.” Source: Scientific American

NIBIB in the News · April 15, 2021

Greenlight Guru, the medtech industry's leading medical device quality management software (MDQMS) platform, today announced its selection as the premier QMS for the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program, led by the National Institute of Biomedical Imaging and Bioengineering. This program aims to improve the speed of innovation in the development, commercialization and implementation of technologies for COVID-19 testing. Source: Prnewswire

NIBIB in the News · April 6, 2021

he US RADx program has spawned a phalanx of diagnostic products to market in just 12 months. Its long-term impact on point-of-care, at-home and population testing may be even more profound. Source: Nature Biotechnology

NIBIB in the News · March 31, 2021

The Centers for Disease Control and Prevention and the National Institutes of Health announced a new initiative on Wednesday to help determine whether frequent, widespread use of rapid coronavirus test slows the spread of the virus. Source: The News Times.

NIBIB in the News · March 31, 2021

Two US counties will receive a surge of free, rapid, at-home Covid-19 tests in an effort to study how people use them and how that impacts Covid-19 trends in the community, according to an announcement Wednesday by the National Institutes of Health. Source: CNN.

NIBIB in the News · March 23, 2021

ROSALIND, a software leader in extracting meaningful insights from diverse pools of life science data, today announced the launch of a web-based platform for monitoring the emergence of SARS-CoV-2 variants and evaluating the effects on the performance of diagnostic tests. The new platform, called the ROSALIND Diagnostic Monitoring (DxM) system, is available starting today and will be used by diagnostic test manufacturers and regulators to monitor assay performance against the rapidly evolving SARS-CoV-2 variants. Source: Business Wire.